Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab) REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines...

United Rheumatology Launches a First-of-its-Kind Outcomes Based Contract in Rheumatoid Arthritis Hauppauge, New York, Feb. 05, 2020 (GLOBE NEWSWIRE) -- United Rheumatology, a rheumatology management services organization, has announced a new pilot program for members of the organization. In a...